Latest News about BMY
Recent news which mentions BMY
Eyes On Novartis, Gilead, Bristol Myers As FDA Weighs Risks Vs. Benefits Of Approved CAR T-Cell Therapies
Today 8:30 EST
From Benzinga
Cabaletta Bio’s and Gracell’s stock falls sharply as FDA investigates risks of CAR-T therapy
November 28, 2023
From MarketWatch
Why Is Avidity Biosciences (RNA) Stock Up 15% Today?
November 28, 2023
From InvestorPlace
Investors beware: ‘Magnificent Seven’ are starting to resemble ‘Nifty 50’ stocks that got crushed in the 1970s market crash
November 28, 2023
From MarketWatch
From Benzinga
Avidity’s stock rockets on Bristol Myers deal that could mean $2.2 billion in milestone payments
November 28, 2023
From MarketWatch
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields
November 27, 2023
From Benzinga
3 Resilient Stocks with Massive Potential to Boost Your Wealth
November 26, 2023
From InvestorPlace
Don't Wait for a Market Crash: These 2 Top Stocks Are on Sale
November 24, 2023
From Motley Fool
From Benzinga
Looking Into Bristol-Myers Squibb's Recent Short Interest
November 21, 2023
Tickers
BMY
From Benzinga
Soothing Stocks: 7 Reliable Picks to Ease Your Market Jitters
November 20, 2023
From InvestorPlace
Analyst Assess Implications of Bristol Myers' Investigational Blood Thinner Post Bayer Trial Setback Amid Shaken Investor Confidence
November 20, 2023
From Benzinga
From Benzinga
Dutch Bros (BROS) Stock Gains on JPMorgan Upgrade
November 20, 2023
From InvestorPlace
From InvestorPlace
Why Is Bristol-Myers Squibb (BMY) Stock Down Today?
November 20, 2023
From InvestorPlace
Why Is Pharma Giant Bristol-Myers Squibb Stock Trading Lower Today?
November 20, 2023
From Benzinga
Bristol Myers Squibb, 2seventy bio shares fall as FDA delays action on cancer treatment
November 20, 2023
From MarketWatch
The stock market has rallied 63 times after a correction. Why this time is different, says Deutsche Bank.
November 20, 2023
From MarketWatch
Bayer shares plunge by more than 20% after trial of potential blockbuster drug halted
November 20, 2023
From MarketWatch
Looking At Bristol-Myers Squibb's Recent Unusual Options Activity
November 17, 2023
Tickers
BMY
From Benzinga
FDA Approves Bristol-Myers' Lung Cancer Drug Acquired Via $4B Turning Point Deal: Competes With Roche, Merck, AstraZeneca
November 16, 2023
From Benzinga
Could Bristol-Myers Squibb Stock Help You Retire A Millionaire?
November 16, 2023
Tickers
BMY
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
November 15, 2023
From Benzinga
Bristol Myers Squibb Proved in Q3 Why Its Diverse Portfolio Makes It a Solid Investment
November 14, 2023
Tickers
BMY
From Motley Fool
Debt-Fueled Buybacks: 3 Stocks Undeterred by Rising Rates
November 13, 2023
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.